Zimmer Biomet Holdings, Inc. · NYSE:ZBH
Zimmer Biomet — Merger or Acquisition (July 2025)
10 slides from Zimmer Biomet's merger presentation, Jul 14, 2025
Slide 1: Acquisition of Monogram Technologies Inc.
MOVING YOU FORWARD July 14, 2025 ZBH Acquisition of Monogram Technologies Inc. Exhibit 99.1
Slide 2: Disclaimer: Cautionary Note Regarding Forward-Looking Statements
Disclaimer Cautionary Note Regarding Forward-Looking Statements: This presentation contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including any statements about us; Monogram Technologies Inc. (“Monogram”);
Slide 3: Summary
Summary Zimmer Biomet has entered into a definitive agreement to acquire all of the outstanding shares of Monogram Technologies Inc. (NASD:MGRM), a developer of semi- and fully-autonomous1, AI-driven orthopedic robotic systems. The transaction values Monogram at approximately $168 million2, is expec
Slide 4: mBôs Overview
mBôs Overview Has not yet received regulatory approval FDA approved to be used with Monogram implants Currently in development, we anticipate late 2027/early 2028 launch KEY FEATURES Robotic joint arm with 7 degrees of freedom Robotic-controlled saw, with capabilities for burring/reaming 1 CT-based
Slide 5: Navigation Robotics Offerings
Navigation Robotics Offerings ZBH’s Full Suite1 of Robotic and Navigational Solutions TMINI4 CT-enabled, handheld, smaller footprint Image-less or CT-enabled pre-planning2, manual cuts ROSA ROBOTIC SYSTEM Inclusion of mBôs as within ZBH’s Suite of Solutions is subject to transaction closing, which i
Slide 6: Robust Robotics Innovation Pipeline
ROSA CT Early-27 ROSA Posterior Hip 2H26 ROSA Oxford 2027 ROSA Shoulder V1.2 2027 mBôs Autonomous with Persona1 Late-27/Early-28 ROSA Shoulder Full launch Early-26 Robust Robotics Innovation Pipeline Committed to advancing all platforms to address customer and patient needs Note: Dates listed are ex
Slide 7: Customer Centric Technology Approach
Customer Centric Technology Approach Autonomous1 Semi-Autonomous Manually Performed Cuts Remote Surgical Capabilities1 CT-based Pre- and Intraoperative- Planning Image Free Planning Markerless Tracking1 Kinematic Alignment Handheld Price Optionality Al-based Augmented-Reality New with mBôs KEY: Has
Slide 8: Transaction Details
Transaction Details Transaction value excludes CVR Based on ZBH internal model expectations, on an adjusted, non-GAAP basis and assuming a 2H2025 deal close Purchase Price and Contingent Value Right (CVR) Structure Sources of Financing Approval Process Financial Impact $4.04 per share in cash corres
Slide 9: Monogram Acquisition Compelling Financial Returns
Driving US robotic knee penetration beyond the roughly 40% exiting 2027 contemplated in our LRP Increasing our share of wallet, as each mBôs case carries a 10-15% price premium Expanding our leading global position in knees Strengthens ZBH’s leadership position in robotics, one of the fastest growin
Slide 10: Transaction Aligns with Our M&A Strategy
Transaction Aligns with Our M&A Strategy Monogram Technologies Checks all the Boxes Strategic Criteria Transaction value (up to $2B) Accelerates WAMGR Adj. EPS Neutral by the End of Year 2 HSD ROIC1 by Year 5 Financial Criteria 1. Return on Invested Capital Path to Category Leadership Differentiated
Zimmer Biomet Holdings — Merger or Acquisition (July 2025) on 6ix